Agilon Health, Inc.
AGL · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$260,101 | -$262,803 | -$106,864 | -$406,787 |
| Dep. & Amort. | $24,463 | $20,161 | $13,772 | $14,670 |
| Deferred Tax | $0 | $0 | $532 | -$3,231 |
| Stock-Based Comp. | $50,657 | $69,326 | $28,381 | $292,394 |
| Change in WC | $130,589 | -$10,067 | -$59,435 | -$55,025 |
| Other Non-Cash | -$3,385 | $27,184 | -$7,194 | $9,820 |
| Operating Cash Flow | -$57,777 | -$156,199 | -$130,808 | -$148,159 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13,251 | -$15,830 | -$15,426 | -$13,426 |
| Net Acquisitions | $0 | -$43,059 | $500 | -$1,344 |
| Inv. Purchases | -$12,006 | -$114,657 | -$458,265 | -$7,095 |
| Inv. Sales/Matur. | $206,915 | $164,040 | $52,548 | $7,095 |
| Other Inv. Act. | -$41,767 | -$34,513 | -$23,745 | -$75,736 |
| Investing Cash Flow | $139,891 | -$44,019 | -$444,388 | -$90,506 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,750 | -$5,000 | -$5,000 | -$19,899 |
| Stock Issued | $1,167 | $11,867 | $33,056 | $1,189,028 |
| Stock Repurch. | $0 | -$200,000 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$14,739 |
| Financing Cash Flow | -$2,583 | -$193,133 | $28,056 | $1,154,390 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $79,531 | -$393,351 | -$547,140 | $915,725 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $114,329 | $507,680 | $1,054,820 | $139,095 |
| End Cash | $193,860 | $114,329 | $507,680 | $1,054,820 |
| Free Cash Flow | -$71,028 | -$187,014 | -$163,469 | -$161,585 |